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Abstract
Background: Low patient adherence to treatment is associated with poorer health outcomes in bronchiectasis. We
sought to use the Theoretical Domains Framework (TDF) (a framework derived from 33 psychological theories) and
behavioural change techniques (BCTs) to define the content of an intervention to change patients’ adherence in
bronchiectasis (Stage 1 and 2) and stakeholder expert panels to define its delivery (Stage 3).
Methods: We conducted semi-structured interviews with patients with bronchiectasis about barriers and
motivators to adherence to treatment and focus groups or interviews with bronchiectasis healthcare professionals
(HCPs) about their ability to change patients’ adherence to treatment. We coded these data to the 12 domain TDF
to identify relevant domains for patients and HCPs (Stage 1). Three researchers independently mapped relevant
domains for patients and HCPs to a list of 35 BCTs to identify two lists (patient and HCP) of potential BCTs for
inclusion (Stage 2). We presented these lists to three expert panels (two with patients and one with HCPs/
academics from across the UK). We asked panels who the intervention should target, who should deliver it, at what
intensity, in what format and setting, and using which outcome measures (Stage 3).
Results: Eight TDF domains were perceived to influence patients’ and HCPs’ behaviours: Knowledge, Skills, Beliefs
about capability, Beliefs about consequences, Motivation, Social influences, Behavioural regulation and Nature of
behaviours (Stage 1). Twelve BCTs common to patients and HCPs were included in the intervention: Monitoring,
Self-monitoring, Feedback, Action planning, Problem solving, Persuasive communication, Goal/target
specified:behaviour/outcome, Information regarding behaviour/outcome, Role play, Social support and Cognitive
restructuring (Stage 2). Participants thought that an individualised combination of these BCTs should be delivered
to all patients, by a member of staff, over several one-to-one and/or group visits in secondary care. Efficacy should
be measured using pulmonary exacerbations, hospital admissions and quality of life (Stage 3).
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Conclusions: Twelve BCTs form the intervention content. An individualised selection from these 12 BCTs will be
delivered to all patients over several face-to-face visits in secondary care. Future research should focus on
developing physical materials to aid delivery of the intervention prior to feasibility and pilot testing. If effective, this
intervention may improve adherence and health outcomes for those with bronchiectasis in the future.
Background
Bronchiectasis is a chronic lung disease with a rising
prevalence in the United States, of 8.7 % per year between
2000 and 2007 [1]. Patients with this condition experience
debilitating symptoms and impaired quality of life [2].
Treatments are burdensome and time-consuming, with
patients prescribed an average of 12 medications as well as
airway clearance techniques to clear lung secretions [3].
Less than 20 % of patients are adherent to all aspects of
treatment [3]. Patients who are non-adherent to inhaled
antibiotics have four pulmonary exacerbations per year,
compared to 2.6 per year in adherent patients [3], indicat-
ing a need to optimise adherence to treatment in this
population. There are no evidence-based interventions
currently available to change adherence for patients with
bronchiectasis [4].
A growing body of evidence advocates the use of psy-
chological theories in the development of interventions
to change behaviour [5–7]. A lack of psychological the-
ory use in the development of adherence interventions
may limit the efficacy and implementation of these inter-
ventions in chronic respiratory disease [8–10]. Conse-
quently, recent guidelines emphasise the need to report
three aspects of behaviour change interventions [11]: (1)
use of psychological theory to identify the factors which
influence the target behaviour change (i.e., mechanism of
action); (2) the active ingredients of behaviour change
interventions (i.e., the content or what was delivered);
and, (3) how this was delivered (i.e., who the interven-
tion targeted, who delivered it, at what intensity, in what
format and setting [12]).
The Theoretical Domains Framework (TDF) [13] can
be used to define the mechanism of action and to
choose behaviour change techniques (BCTs) (“active in-
gredients”) to include in an intervention [7, 14–17]. Two
versions of the TDF exist [13, 18] but only the 12 do-
main version has been used at the time of this study to
select BCTs to include in a behaviour change interven-
tion [13, 16]. Three compilations of BCTs have been
published [7, 14, 17] but only one has been used with
the TDF to define the content of a behaviour change
intervention [7, 16]. Defining the content in this way
does not indicate how this content should be delivered.
Involving key stakeholders represents a potentially useful
method of doing this for an intervention to change ad-
herence in bronchiectasis [16, 19]. Therefore, the aim of
this study was to use a theoretically driven approach, in-
formed by stakeholders’ perspectives to develop an inter-
vention that would focus on changing patient adherence
to treatments in bronchiectasis.
Methods
This study consisted of three stages: to use the TDF to
identify what factors influence patients’ adherence be-
haviour and identify what factors influenced healthcare
professionals’ (HCPs) ability to change the adherence be-
haviour of patients. i.e., mechanism of action of our inter-
vention (Stage 1); use data from Stage 1 to choose the
BCTs i.e., the active ingredients to include in a proposed
intervention (Stage 2); and, use expert panels of key stake-
holders (patients, HCPs and academics) to define how the
proposed intervention could be delivered including format
and delivery, training of HCPs and commissioning of the
proposed intervention in the future (Stage 3). Figure 1
illustrates the three stages of the study.
Stage 1: using the TDF to identify what factors influenced
adherence
Design
We completed two qualitative studies. Firstly, we inter-
viewed patients with bronchiectasis (November 2011-
April 2012). Design, sampling and materials used in
this study have been reported in detail previously [20].
We re-analysed data collected from patient interviews
using the TDF and will only discuss this re-analysis in
this paper. Secondly, between January and June 2013,
we completed semi-structured, mixed-discipline focus
groups and one-to-one interviews with HCPs. One-to-
one interviews were completed with those HCPs who
were unable to attend focus groups.
Sample
We recruited patients with bronchiectasis with a history
of Pseudomonas aeruginosa infection using maximum
variation sampling as they approached the end of a re-
lated study [3, 20]. We recruited HCPs who cared for
patients with bronchiectasis (nurses, physiotherapists,
respiratory physicians, general practitioners [GPs], hos-
pital and community pharmacists and psychologists)
from the five health administrative bodies in Northern
Ireland [Health and Social Care Trusts (HSC)]. Partici-
pants were recruited using a snowballing recruitment
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strategy [21]. We approached existing clinical contacts to
participate in the study and/or to nominate others who
might be interested. Recruitment was supported by the
Northern Ireland Clinical Research Network (specifically
the Respiratory Health and Primary Care Interest Groups)
who approached potential participants (GPs and those in
secondary care in Belfast and Western HSC Trusts). Par-
ticipants were invited via email using an invitation letter
and information sheet. Recruitment continued until data
saturation was reached [21].
Materials and procedure
Both studies used semi-structured topic guides. The pa-
tient guide focused on the factors (barriers and motiva-
tors) influencing adherence to treatments and strategies to
overcome these [20]. The HCP guide focused on know-
ledge of adherence to treatment, perceptions of factors in-
fluencing adherence, ability to change adherence and
views on the important components of an intervention to
change adherence in bronchiectasis (Additional file 1).
Participants in both studies provided informed consent
immediately prior to taking part. The researcher (AMcC)
conducted one-to-one interviews with patients in their
chosen location (hospital or own home) [20]. Two facil-
itators (AMcC and CR) conducted mixed discipline
HCP focus groups in training rooms at seven hospital
sites. Both facilitators were HCPs (physiotherapist and
pharmacist) with experience and training in conducting
qualitative research. The researcher (AMcC) inter-
viewed those who were unable to participate in focus
groups. These took place in the private offices of the
interviewees.
Analysis
All interviews and focus groups were transcribed verba-
tim, anonymised and checked for accuracy by AMcC.
All data were analysed using the 12 domain TDF [13]
(Additional file 1: Tables S1 and S2), patient data were
analysed using an adapted version (Additional file 1:
Table S1). All transcripts were independently analysed
by the researcher (AMcC) and a second member of the
team (JB, BO’N, CH or CR). We coded sections of tran-
scripts to the TDF domains. Each pair of researchers
coded several transcripts then met to agree the approach
to coding. The researcher (AMcC) ensured that all sec-
ond coders were using the same approach; final coding
for each domain was agreed between coders. The re-
searcher (AMcC) analysed the content of each TDF do-
main for both patient and HCP domains to identify key
themes emerging in each. We used this information to
reach consensus on the relevance of each TDF domain
to adherence behaviour for patients and HCPs. We
agreed a domain to be ‘relevant’ if it was frequently
Fig. 1 Summary of stages of data analysis, content and delivery of proposed intervention. aAction planning replaced ‘Time management’ in the
BCT Taxonomy [17]. bSocial support (unspecified) replaced ‘Motivational interviewing’ and ‘Social processes of encouragement, pressure, support’
in the BCT Taxonomy [17]. TDF: Theoretical domains framework. BCTs: Behavioural change techniques. HCP: Healthcare professional
McCullough et al. BMC Health Services Research  (2015) 15:342 Page 3 of 11
coded and the content of the domain linked directly to
the behaviour of interest [22].
Stage 2: using the TDF to choose BCTs to include in the
intervention
To identify BCTs for inclusion, three members of the
team mapped the relevant TDF domains to a list of 35
BCTs using the following method [7] (a list of the 35
BCTs and their definitions are included in Additional file 2:
Table S3). We independently scored whether we would
use each BCT to target each of the 12 TDF domains
using an adapted scoring system from Michie et al. [7]
outlined in Table 1. Additional file 2: Tables S4 and S5
show the final mapping of TDF domains to BCTs for
patients and HCPs.
BCTs for which there was ‘agreed non-use’ were ex-
cluded. We ranked the remaining BCTs based on the
number of TDF domains for which there was ‘agreed use’
or ‘agreed use’ plus ‘disagreement.’ (Additional file 2:
Tables S4 and S5). We discussed, as a team, whether
these BCTs should be included, using the following in-
formation to aid our discussion: (1) BCT ranking; (2)
data on effectiveness of adherence interventions col-
lected as part of a relevant systematic review [4]; (3)
knowledge of the transcript content; (4) whether the
BCT was included, excluded or changed in the BCT
taxonomy which was published during the time this
study was being conducted [17]. From this, we pro-
duced two refined lists of potential BCTs: one to
change patient adherence behaviour and one to change
HCPs’ ability to change adherence. We identified the com-
mon BCTs across the two lists and cross-referenced this
final list of potential BCTs with the BCT taxonomy to
check that the terminology and definitions used were up-
to-date [17]. We adopted this approach of combining the
two lists and cross-referencing with the BCT taxonomy
following personal communications with health psycholo-
gists with specific expertise in applying the TDF and in
BCT coding.
Stage 3: using expert panels to define how the proposed
intervention could be delivered
Design
In April and May 2014, we conducted three expert
panels (patients with P. aeruginosa infection, patients
without P. aeruginosa infection and one HCP/academic
panel). Patients with a history of P. aeruginosa infection
participated in a separate panel from those without P.
aeruginosa to minimise potential cross-infection.
Sample
Patients were eligible if they had high resolution com-
puted tomography diagnosed bronchiectasis and were
prescribed treatments for bronchiectasis. Patients were
recruited by their HCPs from across the five HSC
Trusts, to gain a maximum variation sample based on
gender, location and P.aeruginosa infection status. HCP
and academics from across the United Kingdom were
purposively sampled to obtain a range of expertise
(bronchiectasis management, intervention development,
commissioning of interventions and professional back-
ground). Potential participants were contacted via email
and invited to participate.
Materials and procedure
We summarised the findings from Stages 1 and 2 plus two
related studies (a systematic review of adherence interven-
tions in chronic respiratory disease and a study measuring
predictors of adherence in bronchiectasis [3, 4, 23]) and
circulated these to participants two weeks prior to the ex-
pert panels taking place (Patient version in Additional file 3
and HCP version in Additional file 4). In advance of all
panels, the research team used data from a relevant sys-
tematic review to decide if the BCTs delivered should be
individualised to patients or treatments [4]. We prepared
the following documents to use during the expert panels
(Patient version in Additional file 5 and HCP version in
Additional file 6): (1) a presentation outlining how the
intervention was developed and an agenda for the panel;
(2) a facilitators’ guide for use during the panels; (3) de-
tailed summaries of relevant TDF domains from Stage 1;
(4) a bronchiectasis-specific example for each of the 12
BCTs in the proposed intervention was generated by using
the TDF findings from Stage 1 [7], BCT examples pro-
vided in the BCT taxonomy [17] and findings of a related
systematic review [4]; and, (5) a list of questions to be dis-
cussed during the expert panel meetings based on those
suggested by Davidson et al. [12] (Table 2). During all the
panels, the researcher (AMcC) delivered the presentation
described above. Following this, each panel completed two
tasks (Table 2). Four researchers (AMcC, CR, BO’N and
CH) facilitated the two patient panels. These took place
on the same day (patients without P.aeruginosa infection
in the morning and patients with history of P.aeruginsa in
Table 1 Scoring system for choosing potential BCTs to include
in the intervention
Category for each BCT Scoring for each BCTa
Agreed use Two or more raters scored with a 2 or 3,
except if the third rater scored a 0
Agreed non-use Two or more raters scored with a 0
Disagreement One rater scored with a 0 and two raters
scored with a 2 or 3
Uncertain All other cells in the matrix
aThree raters independently scored each BCT as 0-3, where 0 = no, 1 = possibly,
2 = probably and 3 = definitely
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the afternoon). The single HCP panel was led by six facili-
tators (AMcC, CR, JB, BO’N, SE and CH) and took place
over one day. Participants were split into three small
groups each with specific questions to discuss (Table 2). In
all panels, key discussion points were recorded by desig-
nated members of the research team.
Analysis
The research team conducted a de-brief session follow-
ing all three expert panels. During this session, key find-
ings from each panel were agreed. A copy of these
findings was sent via post or email to the participants of
the respective panels (Additional files 7 and 8). The re-
searcher (AMcC) contacted participants via telephone or
email to obtain feedback on this document which was
added to the overall findings. The research team used
these documents to agree a plan for how the interven-
tion could be delivered in terms of content, who the
intervention should target, who should deliver it, at what
intensity, in what format and setting as well as the pre-
ferred outcome measures, approach to training and
commissioning of the intervention in the future.
Ethical considerations
Ethical approval for all studies was received from the
Office for Research Ethics Northern Ireland (11/NI/
0109 and 12/NI/0078). All HCP/academic participants
who participated in interviews, focus groups or an ex-
pert panel received a Continuing Professional Develop-
ment certificate. Patient and HCP/academic expert
panel participants received a £100 honorarium for par-
ticipating in an expert panel.
Results
Results from stage 1: using the TDF to identify what
factors influenced adherence
Patient participants have been described previously [20].
Briefly, 16 patients with bronchiectasis and moderate
lung impairment participated. Eight were non-adherent
to treatment (inhaled antibiotics, other respiratory medi-
cines and airway clearance) and eight were adherent to
these treatments, based on scoring ≥ 80 % on a self-
reported adherence questionnaire [20].
Seven focus groups of HCPs (n = 39, four to eight par-
ticipants per group) and seven interviews with HCPs
were completed (n = 7). Thirty-eight (83 %) participants
were female with a mean [SD] of 19 [7] years since
qualification. Nine participants worked in primary care
(4 practice nurses, 3 GPs and 2 community pharmacists)
and 37 in secondary care (16 nurses, 10 physiotherapists,
7 respiratory physicians, 2 pharmacists, 2 psychologists).
We identified the same eight domains as being relevant
for patients and HCPs: Knowledge, Skills, Beliefs about
capabilities, Beliefs about consequences, Motivation, Social
Influences, Behavioural regulation and Nature of be-
haviours. Relevant TDF domains, their sub-themes,
summary of domain content and sample quotes are in-
cluded in Tables 3 and 4.
Results from stage 2: using the TDF to choose BCTs to
include in the intervention
Relevant TDF domains mapped against the 35 BCTs and
ranked by number of domains targeted are shown in
Additional file 2: Tables S4 and S5. For patients, 13 po-
tential BCTs were identified as potential components of
an intervention (Table 5). Eleven BCTs were excluded
due to ‘agreed non-use’ and a further 11 were excluded
following discussion within the team (reasons for exclu-
sion are in Additional file 2: Table S6). For HCPs, 17
BCTs were identified as potential components of the
intervention (Table 5). Eight BCTs were excluded due to
‘agreed non-use’ and a further 10 were excluded follow-
ing discussion within the team (reasons for exclusion are
in Additional file 2: Table S7). There were 12 common
BCTs across patient and HCPs (Fig. 1). Following cross-
checking of this final BCT list with the BCT taxonomy,
we updated three of the included BCTs to terms used in
Table 2 Questions explored with expert panels
Task 1: What do you think about our approach to intervention
development?
Task 2 (small group task): Defining how the proposed intervention could
be deliveredTwo patient panels and Group 1 of HCP panel
1. Which patients should the intervention be delivered to?
2. Who should deliver the intervention?
3. How often should the intervention be delivered?
4. For how long should the intervention be delivered?
5. What format should the intervention take?
6. Where should the intervention be delivered?
7. How would you know if the intervention was working? (patients only)
HCP/academic panel (Group 2)
1. Which healthcare professionals should the training be delivered to?
2. Who should deliver the healthcare professional training?
3. How often should the training take place?
4. How long should the training be?
5. What format should the healthcare professional training take?
6. Where should healthcare professional training be delivered?
HCP/academic panel (Group 3)
1. How do you commission services at the moment?
2. How do you commission training for staff at the moment?
3. Would improved adherence be enough to convince you that
this intervention was worth implementing?
4. What would you need to convince you that this intervention
was worth implementing?
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Table 3 Relevant TDF domains, sub-themes, summary of domain content and example quotes for interviews with patients with
bronchiectasis (Stage 1)
Domain label Sub-themes Summary of domain content Example quote
Knowledge Knowledge of treatment Patients had a broad understanding of most
treatments but inhaled antibiotics were less well
understood. Disease knowledge was vague and
misinformed, particularly for knowledge of disease
progression. In most cases, patients thought that
having disease and treatment knowledge improved
adherence.
“I would have to find out exactly why I
was put on it (new treatment)…I don’t
think I would start taking it until I was
satisfied.” (F10A)
Knowledge of disease
Skills Treatment skills Most patients felt they had competent treatment
skills. However, other patients did not feel they
could competently complete airway clearance
and this was a barrier to adherence. Patients
frequently used self-monitoring skills to monitor
symptoms and inform decisions about adherence
either by reinforcing their current adherence
behaviour or prompting a change in behaviour.
“They (physiotherapists) taught me a
method of just sitting up in bed and using
the wedge and doing the drainage that
way.” (F2NA)
Self-monitoring skills
Beliefs about capabilities Psychological capability Patients were generally confident in using inhalers
and oral medication. Nebulised medications and
airway clearance were viewed to be more complex
and some patients felt that they lacked the
psychological capability to do these treatments,
often reporting that doing treatments was
monotonous. Patients thought their physical
capability to adhere would change if they were
older, had physical disabilities or were experiencing
a pulmonary exacerbation.
“I do do it myself but I don’t feel it’s as
good as, em, someone doing it for you…
you’re getting more attention than you’re
giving it yourself.” (F6NA)
Physical capability
Beliefs about consequences Beliefs about necessity
for treatment
Most patients believed that improved symptoms
and quality of life were positive consequences of
adherence. Those who reported a lack of perceived
symptoms or symptomatic improvement following
treatment had a lower perceived need for treatment.
Some patients also believed that there were potential
negative consequences of adherence, such as harm
caused by taking medicines.
“I don’t really need an antibiotic…if I
stopped it for 2 weeks, 3 weeks, 4 weeks I
wouldn’t feel any different.” (M3NA)
Beliefs about harm
caused by treatment
Motivation and goals Intrinsic motivation The majority of patients had high intrinsic
motivation to adhere and prioritised adherence
over other commitments. Some patients struggled
with intrinsic motivation for airway clearance and
inhaled antibiotics. Patients reported a desire to
avoid negative consequences of non-adherence
(hospital admission, pulmonary exacerbations and
decline in quality of life) as goals that increased
motivation to adhere.
“I think, you’ve got to feel it within yourself
that this is what you need to do (adhere
to treatment).” (M14A)Goal to avoid negative
consequences
Social influences Trust in HCPs Patients expressed an inherent trust in HCPs. They
stated that the support of HCPs and other people
with bronchiectasis built their confidence in
managing their condition. Generally patients
reported that their families were supportive but
some did not want to be a burden on their
families and did not involve them in their
treatment. Family, social and working commitments
were seen by some as barriers to adherence.
“I do take them because they (HCPs) tell
me to do that, you know, to take the
whole course (of oral antibiotics).” (M16A)Social support
Competing social
demands
Behavioural regulation Education Patients suggested training on treatment skills,
information on disease progression, reasons for
doing treatment, expected treatment effects and
negative consequences of non-adherence would
encourage patients to adhere. Action planning and
reminder strategies were suggested, with the cav
eat that the latter were only for those with difficulty
remembering to do treatment. Access to and
regular review by a specialist multidisciplinary team
was thought to facilitate adherence. Several non-
adherent patients thought that feedback on
disease progression would facilitate adherence.
“If somebody came along and said to me,
‘if you don’t take that Acapella® or use
that Acapella® every morning and night,
eh, you’re going to get worse, your
bronchiectasis is going to get worse’ then
would probably frighten me into taking it.”
(M5NA)
Action planning
Reminder strategies
Regular review
Feedback on outcome
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the BCT taxonomy. Time management was changed to
Action planning [17]. Motivational interviewing and So-
cial processes of encouragement, pressure, support were
both changed to Social support (unspecified) from the
BCT taxonomy [17].
Results from stage 3: using expert panels to define how
the proposed intervention could be delivered
Eleven patients (64 % female) participated across two
panels (P. aeruginosa panel n = 5 and non-P.aeruginosa
panel n = 6). Nine (78 % female) HCP/academics partici-
pated in a single panel (two nurses, three doctors, two
physiotherapists, two psychologists). Four had expertise
in bronchiectasis, three had experience in behaviour
change interventions and two in both bronchiectasis and
commissioning interventions. Prior to the panels, the re-
search team decided that the proposed intervention
should be able to be individualised to patients and treat-
ments i.e., not all BCTs should be delivered to all pa-
tients but rather BCTs should reflect specific patient or
treatment needs. All panels agreed with this approach
and thought it would be of use to them. Panels’ views on
the format and delivery of the intervention are sum-
marised in Fig. 1. HCP/academics’ views on how training
should be delivered are included in Table 6. HCP/aca-
demics thought that during evaluation of our proposed
intervention pulmonary exacerbations, hospital admis-
sions, lost work days and quality of life should be mea-
sured as these drive the commissioning of future
services. Detailed findings from each of the three panels
are included in Additional files 7 and 8.
Discussion
We have identified eight relevant TDF domains influen-
cing patient adherence to treatment (i.e., the mechanism
of action), used these to define the content for an inter-
vention comprising of 12 BCTs (i.e., the active ingredi-
ents) and used expert panels to determine how this
intervention could be delivered in a research and clinical
setting. To our knowledge, this is the first study to use
this approach for a behaviour change intervention for
patients with chronic respiratory disease. The content
for our intervention has been developed in a systematic
way and using psychological theories to identify 12 po-
tentially effective and well-defined behavioural change
techniques. It is hoped that by using this approach, we
may increase the potential effectiveness of the interven-
tion, its ability to be tested in other disease populations
or be appraised as part of systematic reviews [11]. We
used views of key stakeholders to determine how this
intervention should be delivered, thereby, aiding its abil-
ity to be implemented into clinical practice [5]. If effect-
ive, this intervention has the potential to improve
adherence and health outcomes for patients who suffer
from a disease which can have daily symptoms which
patients perceive as embarrassing [20], leads to frequent
hospitalisations [24] and impairs quality of life [25].
The eight relevant TDF domains were the same for
both patients and HCPs. A recent synthesis of factors af-
fecting adherence reported similar findings to our eight
relevant TDF domains for patients [26]. A single paper
has used the TDF to identify what influenced patients’
behaviour towards haemodialysis care [27] and many
studies have used the TDF to explore factors influencing
HCP behaviours [28–31]. However, to our knowledge,
no other studies have used the TDF to explore HCPs’
perceptions about their ability to influence adherence.
Our data shows that HCPs lacked skills and confidence
around changing patients’ adherence. HCPs identified
that they felt they required training to help them man-
age adherence. Through the expert panels, these data
were used to develop a plan for how HCPs could be
trained to deliver this intervention. Further research is
needed to outline the exact content of this training and
develop the physical materials to facilitate it.
The results of our mapping of the TDF domains to
BCTs are similar in both patients and HCPs, indicating
that it was a rigorous process. Despite the potential for
the TDF and BCTs to develop the content of interven-
tions, few papers have used both frameworks in this
way and all have focused on changing HCP behaviours
[15, 16]. To our knowledge, this is the first paper to de-
fine the content of a behaviour change intervention by
mapping the TDF to BCTs for both patients and HCPs.
The proposed intervention will be individualised for
specific treatments and patients. This decision was taken
Table 3 Relevant TDF domains, sub-themes, summary of domain content and example quotes for interviews with patients with
bronchiectasis (Stage 1) (Continued)
Nature of behaviour Routine Most patients reported that adherence was
something they did automatically. Most patients
linked doing treatments to other activities such as
mealtimes and bedtimes. Treatments that fell
outside of the normal treatment routine or were
more burdensome to integrate (e.g., airway
clearance or inhaled antibiotics) were more likely
to be missed.
“I tend to do mine (treatments) with my
early morning cup of tea and when I’m in
bed at night.” (F12A)
F Female, M Male, 1-16 Interview number, A adherent, NA non-adherent, HCPs healthcare professionals
McCullough et al. BMC Health Services Research  (2015) 15:342 Page 7 of 11
Table 4 Relevant TDF domains, sub-themes, summary of domain content and example quotes for interviews and focus groups with
HCPs (Stage 1)
Domain label Sub-themes Summary of domain content Example quote
Knowledge Clinical knowledge Primary care HCPs lacked knowledge about
bronchiectasis and its management. Better
HCP disease knowledge was thought to
translate to better patient disease knowledge.
HCPs had a broad understanding of the
potential barriers for patient adherence to
treatment. Some HCPs stated that they did
not know what to do to change patients’
adherence.
“There’s probably not as much knowledge
(about bronchiectasis) as there maybe should
be.” (I4_PN)Knowledge of adherence
Skills Interpersonal skills HCPs stated that they used interpersonal
skills such as questioning skills, building
rapport, negotiation, problem-solving and
persuasive communication to change
adherence. Some HCPs felt that they lacked
these skills. Some HCPs had formal post
graduate training in interpersonal skills,
which they thought improved their ability to
change patient adherence.
“I think we would just rely on experience. I
don’t think you’re ever given any specific
training about adherence in any aspect.”
(FG1_HP)
Beliefs about capabilities Confidence in ability to
change adherence
HCPs had a general belief that they had
limited control over changing patients’
adherence. Some lacked confidence in their
ability to change adherence. Others felt
confident in their ability to do this and those
who did, tended to have completed
extended communication skills training.
Several participants appeared pessimistic
about their ability to change their own
behaviours around managing adherence,
this was mainly linked to limitations due to
environmental constraints.
“I kind of dread the patient who I think isn’t
compliant…the ability to honestly challenge a
patient about their compliance without
perhaps losing the relationship, the trust and
stuff… It’s actually a quite challenging thing.”
(FG5_D)
Confidence in ability to
change own behaviour
Beliefs about consequences Positive consequences of
changing adherence
HCPs believed that changing adherence
could lead to positive consequences for the
healthcare system and patients, through
reduced hospital admissions and financial
burden. They evaluated the need to change
patients’ adherence based on their disease
status. They only asked questions about
adherence when patients were unwell. Some
HCPs were concerned about the negative
consequences of discussing adherence, such
as sabotaging their relationship with that
patient and a potentially increased workload.
“(Nurse’s name) and I are trying to do the
bronchiectasis service on top of our (usual
workload), which is a problem, so you know,
in terms of chasing up adherence and chasing
up patients to see what they’re doing isn’t
always as possible.” (FG3_PT2)
Negative consequences
of changing adherence
Motivation and goals Adherence not a priority Changing adherence was not a priority for
HCPs unless patients were unwell or there
was a reason to suspect non-adherence.
Bronchiectasis was not a priority for primary
care participants, who viewed it as a secondary
care problem.
“If they’re not under the umbrella of asthma or
COPD, well it doesn’t matter whether they’re
seen or not [laughs] in theory.” (I1_PN)Bronchiectasis not a
priority for primary care
Social influences Influence of patients Patients strongly influenced HCPs’ clinical
decisions about adherence. Involving
patients in decisions about treatment and
adherence was viewed as being essential to
changing adherence. Effective team working
was thought to increase HCPs’ ability to
manage adherence. A lack of team-working
was evident between primary and secondary
care.
“If the GP changes something or if they
(patients) go to hospital and something has
changed…nobody lets the community
pharmacist know…you sort of fall out of the
loop a wee bit” (FG7_CP)
Influence of other HCPs
Behavioural regulation Patient-focused strategies HCPs suggested patient-focused adherence
strategies such as disease education, goal
setting, action planning, problem-solving,
social support, feedback about disease
progression/adherence. System-focused
strategies included a clear, multidisciplinary
pathway across primary and secondary care.
“(We need) something that has everything in
one book, you know, to explain medications,
airway clearance, exercise, self-management,
anxiety, depression all of those things in one
booklet.” (FG7_PT2)
System-focused strategies
HCP-focused strategies
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prior to the expert panels taking place based on the
strength and breadth of literature supporting this ap-
proach [4, 32, 33]. The HCP panel suggested that there
would need to be an assessment visit to facilitate this.
Several approaches could be used: (1) administering an
assessment questionnaire to evaluate which TDF do-
mains need to be targeted [34]; (2) by identifying re-
sponders and non-responders to particular BCTs or
combinations of BCTs and using that to guide which
BCTs to choose [35]. These approaches present consid-
erable challenges for the design of a future randomised
controlled trial. Future studies will focus on developing
the supporting materials to allow the delivery of the 12
BCTs. As part of feasibility and pilot testing, we will ex-
plore the most appropriate methods of determining
which BCTs to use and test the feasibility of these in dif-
ferent hospital settings.
The effectiveness of the proposed BCTs and plan for
delivery has not yet been tested. Some of the 12 selected
BCTs (information on behaviour and outcomes and cog-
nitive restructuring) have been tested as part of other ef-
fective interventions [36, 37]. As these BCT were used
with other intervention components, the extent to which
they contributed to the effectiveness of these interven-
tions is not known. Further, the optimum method of de-
livery for the included BCTs is not known. Given the
variation in delivery of interventions [36, 37], it appears
Table 4 Relevant TDF domains, sub-themes, summary of domain content and example quotes for interviews and focus groups with
HCPs (Stage 1) (Continued)
Suggested strategies to monitor adherence
included electronically chipped inhalers,
patient diaries, counting tablets and
questioning patients about adherence.
HCP-focused training on consultation skills
was also recognised as being needed.
Nature of behaviours Changing adherence not
part of routine care
HCPs stated that changing adherence was
not part of current routine assessment and
treatment for patients with bronchiectasis.
However, they recognised that data on
number of prescriptions are routinely
collected by GP and pharmacy databases
and thus, could be made available from
primary care to secondary care to enable
monitoring of dispensed items.
“When you’re seeing a bronchiectasis patient
you’re not automatically thinking of adherence.”
(FG3_N1)
I interview, FG focus group, 1-7 interview/focus group number, PN practice nurse, HP hospital pharmacist, D hospital doctor, PT physiotherapist, CP community
pharmacist, N nurse, HCP healthcare professional
Table 5 Patient and HCP BCTs identified as potential
intervention components (Stage 2)
Patient BCTs HCP BCTs
Monitoring Monitoring
Self-monitoring Self-monitoring
Feedback Feedback
Time management Time management
Problem solving Problem solving
Persuasive communication Persuasive communication
Goal/target specified:
behaviour or outcome
Goal/target specified: behaviour
or outcome
Graded task, starting
with easy tasks
Graded task, starting with easy tasks
Information regarding
behaviour, outcome
Information regarding behaviour, outcome
Role play Role play
Motivational interviewing Social processes of encouragement,
pressure and support
Cognitive restructuring Cognitive restructuring
Shaping of behaviour Rewards; incentives including self-evaluation
Contract
Increasing skills; problem solving, decision
making, goal setting
Self-talk
Relapse prevention
HCP healthcare professional, BCT behavioural change techniques
Table 6 HCP/academic panel views on how HCPs should be
trained to deliver the intervention (Stage 3)
Questions posed HCPs/academic panel views
Who to train? Lead HCP at each site. Whole MDT
receive broader, less in-depth training
Who to deliver training? Psychologist or another trained professional
from outside the MDT
Intensity of training? Lead at each site receiving 4 × 2 h sessions,
2 to 3 weeks apart. Mentoring and support
via email or telephone ‘hotline.’ MDT should
receive a half-day training session.
Format of training? Problem-based learning in a group setting
using role plays and case studies
Setting? Convenient location for HCPs
Additional comments Content of HCP training not defined. It was
noted that training on BCTs would need to
be tailored to this specific intervention.
HCP healthcare professional, MDT multidisciplinary team
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that the approach should be tailored to individual inter-
ventions and clinical settings.
There were a number of limitations. The TDF was not
used to design the topic guide for the interviews or focus
groups. Patients were recruited at the end of a related
study on adherence; all patients coming to the end of
the study were invited to participate until data saturation
was reached. However, this may still have affected the
study outcomes. The older compilation of BCTs was
used as the more recent BCT taxonomy containing 93
BCTs was only published during the time our studies
were conducted [17]. However, we attempted to consider
any changes by cross-referencing the final list of in-
cluded BCTs with the BCT taxonomy. Finally, whilst we
obtained a broad range of views, it is difficult to know
whether similar results would be found, particularly for
delivery of the intervention, if this study was replicated
in other healthcare settings with different infrastructure
and systems in place. Snowball sampling of HCPs in
stage 2 may have introduced bias; however, Northern
Ireland has a small healthcare system and we recruited
all of the key respiratory physicians, nurses and physio-
therapists at each hospital site so this is unlikely to be a
significant issue for this study.
Conclusion
We identified 12 theory-derived BCTs that form the
intervention content. Individually tailored content will
be delivered to all patients over several face-to-face visits
in secondary care. Future research should focus on devel-
oping physical materials to aid delivery of the proposed
intervention prior to feasibility and pilot testing. If effect-
ive, this intervention may improve adherence and health
outcomes for those with bronchiectasis in the future.
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